Objective: To ascertain the incidence of massive transfusion (MT) in obstetrics in the UK, and describe its management and clinical outcomes. Design: A population‐based cross‐sectional study conducted through the UK Obstetric Surveillance System (UKOSS). Settings: All UK hospitals with consultant‐led maternity units. Population: Any pregnant woman at ≥20 weeks of gestation receiving ≥8 units of red blood cells within 24 hours of giving birth, from July 2012 to June 2013. Methods: Prospective case identification through the monthly mailing of UKOSS. Results: We identified 181 women who had undergone MT, making the estimated incidence of MT associated with postpartum haemorrhage (PPH) 23 per 100 000 maternities (95% confidence interval 19–26...
International audienceOBJECTIVE: To describe transfusion practices and anemia in women with postpart...
BackgroundThis study aimed to compare incidence, management and outcomes of women transfused their b...
Massive obstetric haemorrhage (MOH) is a leading cause of maternal morbidity and mortality world-wid...
Objective: To ascertain the incidence of massive transfusion (MT) in obstetrics in the UK, and descr...
Objective: To ascertain the incidence of massive transfusion (MT) in obstetrics in the UK, and desc...
Background: The reports on massive transfusions (MTs) in obstetrics have recently been an increasing...
Understanding the coagulopathy of major-obstetric-haemorrhage (MOH) that leads to massive-transfusio...
Understanding the coagulopathy of major-obstetric-haemorrhage (MOH) that leads to massive-transfusio...
Background: Postpartum hemorrhage remains the leading cause of maternal morbidity and mortality worl...
Introduction: Incidence of massive transfusion after birth was high in the Netherlands between 2004 ...
Abstract Background Postpartum hemorrhage remains the leading cause of maternal morbidity and mortal...
Background and objectives: Massive postpartum hemorrhage (PPH) is the most common cause of maternal ...
International audienceOBJECTIVE: To describe transfusion practices and anemia in women with postpart...
BackgroundThis study aimed to compare incidence, management and outcomes of women transfused their b...
Massive obstetric haemorrhage (MOH) is a leading cause of maternal morbidity and mortality world-wid...
Objective: To ascertain the incidence of massive transfusion (MT) in obstetrics in the UK, and descr...
Objective: To ascertain the incidence of massive transfusion (MT) in obstetrics in the UK, and desc...
Background: The reports on massive transfusions (MTs) in obstetrics have recently been an increasing...
Understanding the coagulopathy of major-obstetric-haemorrhage (MOH) that leads to massive-transfusio...
Understanding the coagulopathy of major-obstetric-haemorrhage (MOH) that leads to massive-transfusio...
Background: Postpartum hemorrhage remains the leading cause of maternal morbidity and mortality worl...
Introduction: Incidence of massive transfusion after birth was high in the Netherlands between 2004 ...
Abstract Background Postpartum hemorrhage remains the leading cause of maternal morbidity and mortal...
Background and objectives: Massive postpartum hemorrhage (PPH) is the most common cause of maternal ...
International audienceOBJECTIVE: To describe transfusion practices and anemia in women with postpart...
BackgroundThis study aimed to compare incidence, management and outcomes of women transfused their b...
Massive obstetric haemorrhage (MOH) is a leading cause of maternal morbidity and mortality world-wid...